Literature DB >> 19688599

Formulation of dacarbazine-loaded Cubosomes--part II: influence of process parameters.

Di Bei1, Jacob Marszalek, Bi-Botti C Youan.   

Abstract

The purpose of this study is to investigate the combined influence of process parameters (independent variables) such as homogenization speed (X(1)), duration (X(2)), and temperature (X(3)) during the preparation of dacarbazine-loaded cubosomes. Box-Behnken design was used to rationalize the influence of these three factors on two responses, namely particle size (Y(1)) and encapsulation efficiency (Y(2)). Independent and dependent variables were analyzed with multiple regressions to establish a full-model second-order polynomial equation. F value was calculated to confirm the omission of insignificant parameters or interactions of parameters from the analysis to derive a reduced-model polynomial equation to predict the Y(1) and Y(2) of dacarbazine-loaded cubosomes. Pareto charts were also obtained to show the effects of X(1), X(2), and X(3) on Y(1) and Y(2). For Y(1), there was a model validated for more accurate prediction of response parameter by performing checkpoint analysis. The optimization process and Pareto charts were obtained automatically and they predicted the levels of independent parameters X(1), X(2), and X(3) (0.889794, 0.11886, and 0.56201, respectively) and minimized Y(1). The optimal process parameters (homogenization's speed = approximately 24,000 rpm, duration = 5.5 min, and temperature = 76 degrees C) led to the production of cubosomes with 85.6 nm in size and 16.7% in encapsulation efficiency. The Box-Behnken design proved to be a useful tool in the preparation and optimization of dacarbazine-loaded cubosomes. For encapsulation efficiency (Y(2)), further studies are needed to enhance the result and improve the model for such water-soluble drug encapsulation in cubosomes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19688599      PMCID: PMC2802167          DOI: 10.1208/s12249-009-9296-0

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  20 in total

1.  Lipid-based supramolecular systems for topical application: a preformulatory study.

Authors:  Elisabetta Esposito; Nadia Eblovi; Silvia Rasi; Markus Drechsler; Giordano M Di Gregorio; Enea Menegatti; Rita Cortesi
Journal:  AAPS PharmSci       Date:  2003-11-18

2.  Interaction of cubosomes with plasma components resulting in the destabilization of cubosomes in plasma.

Authors:  Warunee Leesajakul; Minoru Nakano; Atsuhiko Taniguchi; Tetsurou Handa
Journal:  Colloids Surf B Biointerfaces       Date:  2004-04-15       Impact factor: 5.268

3.  Self-assembled lipid superstructures: beyond vesicles and liposomes.

Authors:  Justas Barauskas; Markus Johnsson; Fredrik Tiberg
Journal:  Nano Lett       Date:  2005-08       Impact factor: 11.189

Review 4.  Cubosomes: an overview.

Authors:  Gopal Garg; Shailendra Saraf; Swarnlata Saraf
Journal:  Biol Pharm Bull       Date:  2007-02       Impact factor: 2.233

5.  Effect of drug loading on the transformation of vesicular into cubic nanoparticles during heat treatment of aqueous monoolein/poloxamer dispersions.

Authors:  Gert Wörle; Britta Siekmann; Heike Bunjes
Journal:  Eur J Pharm Biopharm       Date:  2006-02-23       Impact factor: 5.571

6.  Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level Box-Behnken design.

Authors:  Ajay B Solanki; Jolly R Parikh; Rajesh H Parikh
Journal:  AAPS PharmSciTech       Date:  2007-10-19       Impact factor: 3.246

7.  Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG.

Authors:  D Schadendorf; S Ugurel; B Schuler-Thurner; F O Nestle; A Enk; E-B Bröcker; S Grabbe; W Rittgen; L Edler; A Sucker; C Zimpfer-Rechner; T Berger; J Kamarashev; G Burg; H Jonuleit; A Tüttenberg; J C Becker; P Keikavoussi; E Kämpgen; G Schuler
Journal:  Ann Oncol       Date:  2006-01-17       Impact factor: 32.976

8.  Nanostructure of the stratum corneum extracellular lipid matrix as observed by cryo-electron microscopy of vitreous skin sections.

Authors:  L Norlén
Journal:  Int J Cosmet Sci       Date:  2007-10       Impact factor: 2.970

Review 9.  Cubic phase gels as drug delivery systems.

Authors:  J C Shah; Y Sadhale; D M Chilukuri
Journal:  Adv Drug Deliv Rev       Date:  2001-04-25       Impact factor: 15.470

10.  Single-crystal mesostructured semiconductors with cubic Ia3d symmetry and ion-exchange properties.

Authors:  Pantelis N Trikalitis; Krishnaswamy K Rangan; Thomas Bakas; Mercouri G Kanatzidis
Journal:  J Am Chem Soc       Date:  2002-10-16       Impact factor: 15.419

View more
  8 in total

1.  Analysis of process parameters affecting spray-dried oily core nanocapsules using factorial design.

Authors:  Tao Zhang; Bi-Botti C Youan
Journal:  AAPS PharmSciTech       Date:  2010-09-15       Impact factor: 3.246

2.  Formulation of dacarbazine-loaded cubosomes. Part III. Physicochemical characterization.

Authors:  Di Bei; Tao Zhang; James B Murowchick; Bi-Botti C Youan
Journal:  AAPS PharmSciTech       Date:  2010-08-06       Impact factor: 3.246

3.  Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV prevention.

Authors:  Jianing Meng; Tao Zhang; Vivek Agrahari; Miezan J Ezoulin; Bi-Botti C Youan
Journal:  Nanomedicine (Lond)       Date:  2014-01-10       Impact factor: 5.307

4.  Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion.

Authors:  Jianing Meng; Timothy F Sturgis; Bi-Botti C Youan
Journal:  Eur J Pharm Sci       Date:  2011-06-17       Impact factor: 4.384

Review 5.  Engineering nanomedicines for improved melanoma therapy: progress and promises.

Authors:  Di Bei; Jianing Meng; Bi-Botti C Youan
Journal:  Nanomedicine (Lond)       Date:  2010-11       Impact factor: 5.307

6.  Nanosized Cubosomal Thermogelling Dispersion Loaded with Saquinavir Mesylate to Improve Its Bioavailability: Preparation, Optimization, in vitro and in vivo Evaluation.

Authors:  Khaled M Hosny
Journal:  Int J Nanomedicine       Date:  2020-07-16

7.  Preclinical assessment of nanostructured liquid crystalline particles for the management of bacterial keratitis: in vivo and pharmacokinetics study.

Authors:  Shreya Kaul; Upendra Nagaich; Navneet Verma
Journal:  Drug Deliv Transl Res       Date:  2021-09-28       Impact factor: 4.617

Review 8.  Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A Review.

Authors:  Roberta Balansin Rigon; Márcia Helena Oyafuso; Andressa Terumi Fujimura; Maíra Lima Gonçalez; Alice Haddad do Prado; Maria Palmira Daflon Gremião; Marlus Chorilli
Journal:  Biomed Res Int       Date:  2015-05-11       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.